Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1u54 | ACP | Activated CDC42 kinase 1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 1.000 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.541 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.459 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.450 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.448 | |
| 2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.448 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.448 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.448 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.447 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.446 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.445 | |
| 4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.440 |